The Valley Desk

ArticleJournal of the American Academy of DermatologyPublished

Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Journal of the American Academy of Dermatology
Published
Subject terms
Adolescents; Plaque Psoriasis; Patient-reported Outcomes; Oral Peptide; Icotrokinra; Iconic-lead
PubMed ID
42144198
Added to directory
Source checked

Report a correction or request removal